Akzo Nobel subsidiary Organon is to work with Amsterdam’s AMC teaching hospital on developing a new treatment for rheumatoid arthritis and possibly other diseases, Organon said on Wednesday. .
Organon is to continue research and development for the treatment, which was initially developed by the AMC, and will have an exclusive licence to market it. Financial details were not disclosed. One in 10 Dutch people suffer from some sort of rheumatism.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.Make a donation